英文名稱(chēng) | Bevacizumab (anti-VEGF) | RhuMab VEGF |
---|---|
中文名稱(chēng) | 貝伐單抗 |
CAS號(hào) | 216974-75-3 |
分子量 | 149 kDa |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥1500.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥6000.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥12000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥48000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥768000.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Bevacizumab (anti-VEGF) | RhuMab VEGF |
---|---|
中文名稱(chēng) | 貝伐單抗 |
CAS號(hào) | 216974-75-3 |
分子量 | 149 kDa |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.